Download PDF
Dtsch Med Wochenschr 2022; 147(19): 1266-1276
DOI: 10.1055/a-1767-8423
Dossier

Kongenitale hämolytische Anämien durch Membran- und Enzymdefekte der Erythrozyten

Congenital hemolytic anemias due to erythrocyte membrane and enzyme defects
Franziska Génevaux
,
Annika Bertsch
,
Lisa Wiederer
,
Stefan Eber
› Further Information
Also available at
    Permissions and Reprints

Membran- und Enzymdefekte der Erythrozyten können schwere, zum Teil chronisch transfusionsbedürftige Anämien verursachen und mit akut anämisierenden aplastischen Krisen einhergehen. Die exakte Kenntnis dieser Anämien ermöglicht eine patientenorientierte personale Therapie.

Abstract

Erythrocyte membrane and enzyme defects are the most common cause of congenital hemolytic anemias in the Central European population. Diagnostics include erythrocyte morphology, special biochemical tests such as osmotic fragility (AGLT) and EMA. For enzymopenic hemolytic anemias, cost-effective biochemical analysis remains the gold standard, supplemented by molecular genetic diagnostics when appropriate. Therapeutically, near complete splenectomy reduces hemolysis significantly for spherocytosis. The residual spleen at least provides a considerable phagocytic function and better response to immunisation and by inference possibly better protection against severe post-splenectomy infection. For pyruvate kinase deficiency, which is not so rare, a new molecular therapy (Mitapivat) is currently being introduced. In G6PD deficiency, there are very few drugs that cause hemolytic crisis. Sudden onset of hemoglobinuria is an early important hallmark of severe hemolytic crisis in G6PD deficiency and these patients should be hospitalized. Aplastic crises in the setting of parvovirus B19 infection occur in all congenital hemolytic anemias. Transfusion is not preventable in most cases. Iron-excreting treatment is required in the rare patients in need of chronic transfusion.

Schlüsselwörter

Hereditäre Sphärozytose - Hereditäre Elliptozytose - Hereditäre Stomatozytose - Pyruvatkinase-Mangel Pyrimidin-5’-Nucleotidase Mangel - Glucose-6-Phosphat-Dehydrogenase-Mangel

Key words

hereditary spherocytosis - hereditary ellipocytosis - hereditary stomatocytosis - pyruvate kinase deficiency - pyrimidin 5’-nucleotidase deficiency - G6PD deficiency


Publication History

Article published online:
20 September 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 An X, Mohandas N. Disorders of red cell membrane. Br J Haematol 2008; 141: 367-375
    CrossrefPubMedSearch in Google Scholar
  • 2 Vagace JM, Bajo R, Gervasini G. Diagnostic and therapeutic challenges of primary autoimmune haemolytic anaemia in children. Arch Dis Child 2014; 99: 668-673
    CrossrefPubMedSearch in Google Scholar
  • 3 Gallagher PG. Disorders of red cell volume regulation. Curr Opin Hematol 2013; 20: 201-207
    CrossrefPubMedSearch in Google Scholar
  • 4 Zamora EA, Schaefer CA. Hereditary Spherocytosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
    Search in Google Scholar
  • 5 Da Costa L, Galimand J, Fenneteau O. et al. Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev 2013; 27: 167-178
    CrossrefPubMedSearch in Google Scholar
  • 6 Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet 2008; 372: 1411-1426
    CrossrefPubMedSearch in Google Scholar
  • 7 Eber S, Andres O. Hereditäre Sphärozytose. AWMF S1 Leitlinie, Register Nr. 025/018. 2016
    PubMedSearch in Google Scholar
  • 8 He Y, Jia S, Dewan RK. et al. Novel mutations in patients with hereditary red blood cell membrane disorders using next-generation sequencing. Gene 2017; 627: 556-562
    CrossrefPubMedSearch in Google Scholar
  • 9 Iolascon A, Avvisati RA, Piscopo C. Hereditary spherocytosis. Transfus Clin Biol 2010; 17: 138-142
    CrossrefPubMedSearch in Google Scholar
  • 10 He BJ, Liao L, Deng ZF. et al. Molecular Genetic Mechanisms of Hereditary Spherocytosis: Current Perspectives. Acta Haematol 2018; 139: 60-66
    CrossrefPubMedSearch in Google Scholar
  • 11 Bolton-Maggs PH, Langer JC, Iolascon A. et al. Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. Br J Haematol 2012; 156: 37-49
    CrossrefPubMedSearch in Google Scholar
  • 12 Kiliç MA, Özdemir GN, Tahtakesen TN. et al. Clinical Features and Outcome of Children With Hereditary Spherocytosis. J Pediatric Hematol Oncol 2022; 44: e306-e309
    CrossrefPubMedSearch in Google Scholar
  • 13 Kobayashi Y, Hatta Y, Ishiwatari Y. et al. Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature. BMC Res Notes 2014; 7: 137
    CrossrefPubMedSearch in Google Scholar
  • 14 Steward SC, Chauvenet AR, OʼSuoji CC. Hereditary spherocytosis: Consequences of delayed diagnosis. SAGE Open Medicine 2014; 2
    CrossrefPubMedSearch in Google Scholar
  • 15 Eber S, Lux SE. Hereditary spherocytosis--defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004; 41: 118-141
    CrossrefPubMedSearch in Google Scholar
  • 16 Bobée V, Daliphard S, Schrapp A. et al. Screening of hereditary spherocytosis and pyruvate kinase deficiency by automated blood count using erythrocytic and reticulocytic parameters. Int J Lab Hematol 2018; 40: 697-703
    CrossrefPubMedSearch in Google Scholar
  • 17 Nair SC, Arora NK, Jain S. et al. Mean reticulocyte volume enhances the utility of red cell mean sphered cell volume in differentiating peripheral blood spherocytes of hereditary spherocytosis from other causes. Ind J Pathol Microbiol 2015; 58: 307-309
    CrossrefPubMedSearch in Google Scholar
  • 18 Casale M, Perrotta S. Splenectomy for hereditary spherocytosis: complete, partial or not at all?. Expert Rev Hematol 2011; 4: 627-635
    CrossrefPubMedSearch in Google Scholar
  • 19 Pincez T, Guitton C, Gauthier F. et al. Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study. Blood 2016; 127: 1616-1618
    CrossrefPubMedSearch in Google Scholar
  • 20 Pincez T, Guitton C, Landman-Parker J. et al. Subtotal and total splenectomy for hereditary pyropoikilocytosis: Benefits and outcomes. Am J Hematol 2018; 93: E340-E342
    CrossrefPubMedSearch in Google Scholar
  • 21 Stoehr GA, Sobh JN, Luecken J. et al. Near-total splenectomy for hereditary spherocytosis: clinical prospects in relation to disease severity. Brit J Haematol 2006; 132: 791-793
    CrossrefPubMedSearch in Google Scholar
  • 22 Stoehr GA, Luecken J, Zielen S. et al. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis. Brit J Surg 2008; 95: 466-471
    CrossrefPubMedSearch in Google Scholar
  • 23 Matsumoto R, Yoshiyama K, Yokoyama S. et al. Surgical resection of extramedullary haematopoiesis in the posterior mediastinum. Respirol Case Rep 2018; 6: e00358
    CrossrefPubMedSearch in Google Scholar
  • 24 Mühlberger D. Deutsche Gesellschaft für Phlebologie. Diagnostik und Therapie des Ulcus cruris venosum; Überarbeitung AWMF Leitlinie S2k, Register Nr. 037-009; geplante Fertigstellung 12/2022.
    PubMed
  • 25 Wang GJ, Gao CF, Wei D. et al. Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol 2009; 15: 1427-1430
    CrossrefPubMedSearch in Google Scholar
  • 26 Andolfo I, Russo R, Gambale A. et al. Hereditary stomatocytosis: An underdiagnosed condition. Am J Hematol 2018; 93: 107-121
    CrossrefPubMedSearch in Google Scholar
  • 27 Gesellschaft für Pädiatrische Onkologie und Hämatologie. Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien, AWMF Leitlinie S2k. Registernummer 025-029. 2022
    PubMedSearch in Google Scholar
  • 28 Butorac Ahel I, Baraba Dekanic K, Palcevski G. et al. An Infant With Unusually High Unconjugated Hyperbilirubinemia Due to Coexistence of Hereditary Spherocytosis and Gilbert Syndrome. J Ped Hematol Oncol 2018; 40: e127-e128
    CrossrefPubMedSearch in Google Scholar
  • 29 Vayá A, Suescun M, Pardo A. et al. Erythrocyte deformability and hereditary elliptocytosis. Clin Hemorheol Microcirc 2014; 58: 471-473
    CrossrefPubMedSearch in Google Scholar
  • 30 Niss O, Chonat S, Dagaonkar N. et al. Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells Mol Dis 2016; 61: 4-9
    CrossrefPubMedSearch in Google Scholar
  • 31 Gallagher PG. Hereditary elliptocytosis: spectrin and protein 4.1R. Semin Hematol 2004; 41: 142-164
    CrossrefPubMedSearch in Google Scholar
  • 32 Singh V, Roberts S, Baden H. Hereditary stomatocytosis. Eur J Haematol 2008; 81: 410
    CrossrefPubMedSearch in Google Scholar
  • 33 Eber S. Angeborene Erythrozytenmembrandefekte. In: Gadner H, Gaedicke G, Niemeyer C. et al., Hrsg. Pädiatrische Hämatologie und Onkologie. Berlin, Heidelberg: Springer; 2006: 123-138
    CrossrefSearch in Google Scholar
  • 34 Frederiksen H. Dehydrated hereditary stomatocytosis: clinical perspectives. J Blood Med 2019; 10: 183-191
    CrossrefPubMedSearch in Google Scholar
  • 35 Layton DM, Bain BJ. Dehydrated hereditary stomatocytosis. Am J Hematol 2016; 91: 266
    CrossrefPubMedSearch in Google Scholar
  • 36 Halma J, Petrikin J, Daniel JF. et al. Dehydrated Hereditary Stomatocytosis Presenting as Severe Perinatal Ascites and Cholestasis. J Pediatr Gastroenterol Nutr 2019; 68: e52-e53
    CrossrefPubMedSearch in Google Scholar
  • 37 Zama D, Giulietti G, Muratore E. et al. A novel PIEZO1 mutation in a patient with dehydrated hereditary stomatocytosis: a case report and a brief review of literature. Ital J Pediatr 2020; 46: 102
    CrossrefPubMedSearch in Google Scholar
  • 38 Jenner B, Brockelsby J, Thomas W. Dehydrated hereditary stomatocytosis causing fetal hydrops and perinatal ascites. Brit J Haematol 2018; 182: 620-620
    CrossrefPubMedSearch in Google Scholar
  • 39 Alberto Z, Paola B, Elisa F. Pyruvate kinase deficiency. Haematologica 2007; 92: 721-723
    CrossrefPubMedSearch in Google Scholar
  • 40 Handin RI, Lux SE, Stossel TP. Blood: Principles and Practice of Hematology. Philadelphia: Lippincott Williams and Wilkins; 1995
    Search in Google Scholar
  • 41 Pekrun A, Lakomek M, Eber S. et al. Diagnosis of pyruvate kinase deficiency in the presence of an elevated reticulocyte count. Dtsch Med Wochenschr 1995; 120: 1620-1624
    Thieme ConnectPubMedSearch in Google Scholar
  • 42 Al-Samkari H, Galactéros F, Glenthøj A. et al. Mitapivat versus Placebo for Pyruvate Kinase Deficiency. N Engl J Med 2022; 386: 1432-1442
    CrossrefPubMedSearch in Google Scholar
  • 43 Rees DC, Duley JA, Marinaki AM. Pyrimidine 5′ Nucleotidase Deficiency. Br J Haematol 2003; 120: 375-383
    CrossrefPubMedSearch in Google Scholar
  • 44 Youngster I, Arcavi L, Schechmaster R. et al. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf 2010; 33: 713-726
    CrossrefPubMedSearch in Google Scholar
  • 45 Eber S, Andres O. Anämien. Monatsschr Kinderheilk 2016; 164: 59-72
    CrossrefPubMedSearch in Google Scholar
  • 46 van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood 2005; 106: 4034-4042
    CrossrefPubMedSearch in Google Scholar